Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (N-Term) Peptide

Details for Product No. ABIN1382896, Supplier: Log in to see
Protein Name
  • C9orf12
  • RGD1311271
  • rIpk1
  • RIP
  • RIP1
  • D330015H01Rik
  • Rinp
  • Rip1
  • 2400006N03Rik
  • RP23-83I13.5
  • Rip
  • receptor (TNFRSF)-interacting serine-threonine kinase 1
  • inositol 1,3,4,5,6-pentakisphosphate 2-kinase
  • RPA interacting protein
  • LOC100230522
  • Ippk
  • RIPK1
  • Ripk1
  • Rpain
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-RIPK1 antibody (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1) (N-Term) (ABIN1031543)
Characteristics 15 amino acids near the amino terminus of human RIPK1.
Application Notes RIPK1 peptide is used for blocking the activity of RIPK1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Stanger, Leder, Lee, Kim, Seed: "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death." in: Cell, Vol. 81, Issue 4, pp. 513-23, 1995 (PubMed).